Entia Biosciences, Inc. (ERGO)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 2, 2025
Entia Biosciences Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ERGO has 34.06 million shares outstanding.
| Current Share Class | 34.06M |
| Shares Outstanding | 34.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -164.37% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 70.05% |
| Revenue Per Employee | 37,924 |
| Profits Per Employee | -199,397 |
| Employee Count | 7 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 21.02 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 40.96 |
| Average Volume (20 Days) | 22,296 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, ERGO had revenue of 265,466 and -1.40 million in losses. Loss per share was -0.05.
| Revenue | 265,466 |
| Gross Profit | 173,967 |
| Operating Income | -1.17M |
| Pretax Income | -1.40M |
| Net Income | -1.40M |
| EBITDA | -1.15M |
| EBIT | -1.17M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 76,050 in cash and 1.05 million in debt, giving a net cash position of -969,950 or -0.03 per share.
| Cash & Cash Equivalents | 76,050 |
| Total Debt | 1.05M |
| Net Cash | -969,950 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -1.97M |
| Book Value Per Share | -0.07 |
| Working Capital | -1.87M |
Cash Flow
| Operating Cash Flow | -715,098 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 65.53% |
| Operating Margin | -439.75% |
| Pretax Margin | -525.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ERGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.84% |
| Shareholder Yield | n/a |
| Earnings Yield | -40,980.09% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on February 15, 2012. It was a reverse split with a ratio of 0.1.
| Last Split Date | Feb 15, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
ERGO has an Altman Z-Score of -58.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -58.94 |
| Piotroski F-Score | n/a |